ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs MXN
16.539
-0.10%
Brent Oil
82.965
-0.68%
Bitcoin
71,029.77
-0.59%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cumberland Pharmaceutical Inc (CPIX)

  7. Cumberland Pharmaceutical Inc (CPIX) Noticias

CPIX

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CPIX
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202416:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202415:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202415:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202415:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202415:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202415:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202416:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
28/12/202316:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
26/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202315:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202316:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
06/12/202316:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202315:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202315:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
10/10/202315:05PR Newswire (US)NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGENASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202309:55Dow Jones NewsCorrection to SEC Fines ArticleNASDAQ:CPIXCumberland Pharmaceutical Inc
27/09/202309:43Dow Jones NewsSEC Fines 5 Public Companies, Insiders Over Reporting FailuresNASDAQ:CPIXCumberland Pharmaceutical Inc
08/08/202315:05PR Newswire (US)Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023NASDAQ:CPIXCumberland Pharmaceutical Inc
01/08/202315:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
26/06/202308:00PR Newswire (US)NEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN PEDIATRIC PATIENTSNASDAQ:CPIXCumberland Pharmaceutical Inc
22/06/202305:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
23/05/202308:00PR Newswire (US)CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND FOR NEW TREATMENT OF IDIOPATHIC PULMONARY FIBROSISNASDAQ:CPIXCumberland Pharmaceutical Inc
16/05/202316:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/05/202308:00PR Newswire (US)CALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN INFANTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/05/202315:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
02/05/202315:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
27/03/202316:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPIXCumberland Pharmaceutical Inc
15/03/202306:41Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CPIXCumberland Pharmaceutical Inc
13/03/202316:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CPIXCumberland Pharmaceutical Inc
 Showing the most relevant articles for your search:NASDAQ:CPIX

Su Consulta Reciente

CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
FX
USDMXN
US Dollar vs MXN
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
NASDAQ
AMZN
Amazon.com
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
NYSE
NKE
Nike
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados